Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Cooling the scalp below 22°C before and during chemotherapy can help prevent hair loss.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Tamoxifen caused hair loss in a 52-year-old woman.

Higher DHT in male baldness may protect against prostate cancer.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

PLD is an effective and safer alternative for treating breast cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Physical activity, height, and smoking affect prostate cancer risk.

A group has developed therapies that show promise for treating cancer and various other conditions.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.